investorscraft@gmail.com

Intrinsic Value of Viveve Medical, Inc. (VIVE)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %17.3NaN
Revenue, $6NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m28NaN
Operating income, $m-22NaN
EBITDA, $m-20NaN
Interest expense (income), $mNaN
Earnings before tax, $m123NaN
Tax expense, $m150NaN
Net income, $m-27NaN

BALANCE SHEET

Cash and short-term investments, $m19NaN
Total assets, $m26NaN
Adjusted assets (=assets-cash), $m7NaN
Average production assets, $m8175NaN
Working capital, $m18NaN
Total debt, $m5NaN
Total liabilities, $m11NaN
Total equity, $m15NaN
Debt-to-equity ratio0.355NaN
Adjusted equity ratio-0.573NaN

CASH FLOW

Net income, $m-27NaN
Depreciation, amort., depletion, $m1NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-13NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-0NaN
Free cash flow, $m-12NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m18
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount